vs

Side-by-side financial comparison of MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) and Ranpak Holdings Corp. (PACK). Click either name above to swap in a different company.

Ranpak Holdings Corp. is the larger business by last-quarter revenue ($93.7M vs $49.9M, roughly 1.9× MARAVAI LIFESCIENCES HOLDINGS, INC.). On growth, Ranpak Holdings Corp. posted the faster year-over-year revenue change (2.3% vs -11.8%). Over the past eight quarters, Ranpak Holdings Corp.'s revenue compounded faster (13.7% CAGR vs -11.9%).

Maravai LifeSciences Holdings is a global life sciences firm developing critical reagents, diagnostic products, and tech solutions to support biopharma research, drug development, clinical diagnostics, and cell/gene therapy manufacturing. It serves biotech, pharma, research bodies and labs worldwide across three core segments.

Ranpak Holdings Corp. manufactures machines and paper products used in protective paper-based packing for shipping goods and merchandise for e-commerce and industry, along with automation solutions. The company is based in Concord, Ohio, and has production facilities and offices in Reno, Nevada; Kansas City, Missouri; the Netherlands; Czech Republic; Shanghai and Singapore. The paper packaging material can be used for multiple applications like wrapping, cushioning, void fill and cold chain p...

MRVI vs PACK — Head-to-Head

Bigger by revenue
PACK
PACK
1.9× larger
PACK
$93.7M
$49.9M
MRVI
Growing faster (revenue YoY)
PACK
PACK
+14.1% gap
PACK
2.3%
-11.8%
MRVI
Faster 2-yr revenue CAGR
PACK
PACK
Annualised
PACK
13.7%
-11.9%
MRVI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MRVI
MRVI
PACK
PACK
Revenue
$49.9M
$93.7M
Net Profit
$-35.7M
Gross Margin
25.8%
39.0%
Operating Margin
-117.9%
-1.0%
Net Margin
-71.6%
Revenue YoY
-11.8%
2.3%
Net Profit YoY
-37.7%
EPS (diluted)
$-0.24
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MRVI
MRVI
PACK
PACK
Q4 25
$49.9M
$93.7M
Q3 25
$41.6M
$83.6M
Q2 25
$47.4M
$77.8M
Q1 25
$46.9M
$77.6M
Q4 24
$56.6M
$91.6M
Q3 24
$69.0M
$78.6M
Q2 24
$69.4M
$72.8M
Q1 24
$64.2M
$72.5M
Net Profit
MRVI
MRVI
PACK
PACK
Q4 25
$-35.7M
Q3 25
$-25.6M
$-10.4M
Q2 25
$-39.6M
$-7.5M
Q1 25
$-29.9M
$-10.9M
Q4 24
$-25.9M
Q3 24
$-97.1M
$-8.1M
Q2 24
$-9.8M
$5.5M
Q1 24
$-12.1M
$-8.1M
Gross Margin
MRVI
MRVI
PACK
PACK
Q4 25
25.8%
39.0%
Q3 25
13.6%
41.1%
Q2 25
16.4%
37.1%
Q1 25
16.5%
39.8%
Q4 24
34.3%
45.2%
Q3 24
46.7%
43.8%
Q2 24
44.4%
43.5%
Q1 24
40.3%
44.6%
Operating Margin
MRVI
MRVI
PACK
PACK
Q4 25
-117.9%
-1.0%
Q3 25
-98.6%
-6.8%
Q2 25
-139.8%
-12.5%
Q1 25
-104.9%
-10.3%
Q4 24
-66.7%
1.5%
Q3 24
-239.9%
-5.3%
Q2 24
-19.4%
-7.1%
Q1 24
-29.4%
-6.6%
Net Margin
MRVI
MRVI
PACK
PACK
Q4 25
-71.6%
Q3 25
-61.4%
-12.4%
Q2 25
-83.5%
-9.6%
Q1 25
-63.9%
-14.0%
Q4 24
-45.8%
Q3 24
-140.6%
-10.3%
Q2 24
-14.1%
7.6%
Q1 24
-18.8%
-11.2%
EPS (diluted)
MRVI
MRVI
PACK
PACK
Q4 25
$-0.24
$-0.11
Q3 25
$-0.18
$-0.12
Q2 25
$-0.27
$-0.09
Q1 25
$-0.21
$-0.13
Q4 24
$-0.21
$-0.13
Q3 24
$-0.68
$-0.10
Q2 24
$-0.07
$0.07
Q1 24
$-0.09
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MRVI
MRVI
PACK
PACK
Cash + ST InvestmentsLiquidity on hand
$216.9M
$63.0M
Total DebtLower is stronger
$291.8M
$401.9M
Stockholders' EquityBook value
$212.4M
$534.9M
Total Assets
$770.6M
$1.1B
Debt / EquityLower = less leverage
1.37×
0.75×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MRVI
MRVI
PACK
PACK
Q4 25
$216.9M
$63.0M
Q3 25
$243.6M
$49.9M
Q2 25
$269.9M
$49.2M
Q1 25
$285.1M
$65.5M
Q4 24
$322.4M
$76.1M
Q3 24
$578.2M
$69.5M
Q2 24
$573.2M
$65.1M
Q1 24
$561.7M
$55.1M
Total Debt
MRVI
MRVI
PACK
PACK
Q4 25
$291.8M
$401.9M
Q3 25
$292.8M
$403.1M
Q2 25
$293.9M
$403.1M
Q1 25
$294.9M
$405.2M
Q4 24
$295.9M
$406.4M
Q3 24
$521.7M
$403.2M
Q2 24
$522.5M
$396.1M
Q1 24
$523.3M
$396.7M
Stockholders' Equity
MRVI
MRVI
PACK
PACK
Q4 25
$212.4M
$534.9M
Q3 25
$245.4M
$537.8M
Q2 25
$265.9M
$539.0M
Q1 25
$300.6M
$544.1M
Q4 24
$325.3M
$548.1M
Q3 24
$344.9M
$564.3M
Q2 24
$434.7M
$566.2M
Q1 24
$410.7M
$560.0M
Total Assets
MRVI
MRVI
PACK
PACK
Q4 25
$770.6M
$1.1B
Q3 25
$849.2M
$1.1B
Q2 25
$897.0M
$1.1B
Q1 25
$959.8M
$1.1B
Q4 24
$1.0B
$1.1B
Q3 24
$1.3B
$1.1B
Q2 24
$1.4B
$1.1B
Q1 24
$1.4B
$1.1B
Debt / Equity
MRVI
MRVI
PACK
PACK
Q4 25
1.37×
0.75×
Q3 25
1.19×
0.75×
Q2 25
1.11×
0.75×
Q1 25
0.98×
0.74×
Q4 24
0.91×
0.74×
Q3 24
1.51×
0.71×
Q2 24
1.20×
0.70×
Q1 24
1.27×
0.71×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MRVI
MRVI
PACK
PACK
Operating Cash FlowLast quarter
$-22.8M
$19.5M
Free Cash FlowOCF − Capex
$-24.9M
FCF MarginFCF / Revenue
-49.9%
Capex IntensityCapex / Revenue
4.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-70.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MRVI
MRVI
PACK
PACK
Q4 25
$-22.8M
$19.5M
Q3 25
$-15.2M
$8.5M
Q2 25
$-10.3M
$-3.6M
Q1 25
$-9.4M
$-1.3M
Q4 24
$-14.6M
$6.5M
Q3 24
$13.1M
$10.1M
Q2 24
$17.4M
$19.6M
Q1 24
$-8.5M
$5.2M
Free Cash Flow
MRVI
MRVI
PACK
PACK
Q4 25
$-24.9M
Q3 25
$-18.1M
Q2 25
$-13.1M
Q1 25
$-14.6M
Q4 24
$-20.5M
Q3 24
$4.5M
Q2 24
$7.9M
Q1 24
$-14.1M
FCF Margin
MRVI
MRVI
PACK
PACK
Q4 25
-49.9%
Q3 25
-43.4%
Q2 25
-27.7%
Q1 25
-31.2%
Q4 24
-36.2%
Q3 24
6.6%
Q2 24
11.4%
Q1 24
-22.0%
Capex Intensity
MRVI
MRVI
PACK
PACK
Q4 25
4.2%
Q3 25
7.0%
Q2 25
6.1%
Q1 25
11.2%
Q4 24
10.3%
Q3 24
12.4%
Q2 24
13.8%
Q1 24
8.8%
Cash Conversion
MRVI
MRVI
PACK
PACK
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
3.56×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MRVI
MRVI

Cygnus Segment$27.2M54%
Other$18.4M37%
Shipping And Handling$4.3M9%

PACK
PACK

Other$47.9M51%
Europe And Asia Segment$45.8M49%

Related Comparisons